No Break for Pharma: Third Circuit Refuses to Stay Anti Pay-for-Delay

Washington Drug Letter
Drugmakers operating in the Third Circuit Court of Appeals jurisdiction will need to remain cautious about engaging in reverse patent settlements as the court refused to put on hold its recent ruling that such deals are anticompetitive while Merck and Upsher-Smith appeal to the Supreme Court.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00